Neal Murphy
Hofstra University
6 Papers
Neal Murphy is an academic researcher from Hofstra University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Paraneoplastic Syndrome Secondary to Treatment Emergent Neuroendocrine Tumor in Metastatic Castration-resistant Prostate Cancer: A Unique Case.
Neal Murphy,Janice Shen,Andrew Shih,Anthony Liew,Houman Khalili,Oksana Yaskiv,Kyle Katona,Annette Lee,Xinhua Zhu +8 more
TL;DR: This case features a paraneoplastic Cushing syndrome, initial resistance to androgen receptortargeted therapy, a continuously rising prostatespecific antigen, and a lack of disease spread to visceral organs.
5
Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas
Andrew Shih,Neal Murphy,Zachary Kozel,Zachary Kozel,Paras Shah,Oksana Yaskiv,Houman Khalili,Anthony Liew,Louis R. Kavoussi,Louis R. Kavoussi,Simon Hall,Simon Hall,Manish Vira,Manish Vira,Xinhua Zhu,Annette Lee,Annette Lee +16 more
TL;DR: These results identify molecular signatures for more aggressive tumors in clinically low risk ccRCC patients who have a higher potential of metastasis than would be expected.
Smoking cessation after cancer diagnosis: Relationships matter.
TL;DR: Being diagnosed with cancer can serve as a teachable moment and motivate patients to quit smoking, and the odds of quitting was lower in patients who lived with smokers than those who did not, though not statistically significant likely due to small sample size.
Journal Article
The Evolving Role of PD-L1 Inhibition in Non-Small Cell Lung Cancer: A Review of Durvalumab and Avelumab.
M Neumann,Neal Murphy,Nagashree Seetharamu +2 more
- 01 Apr 2022
TL;DR: In this article , the authors focus on two of the newer PD-L1 inhibitors, durvalumab and avelumab, for non-small cell lung cancer (NSCLC).
Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients.
TL;DR: In this paper, the authors evaluate and target patients' social networks to encourage smoking cessation in both patients and relevant family members, such as family, friends, and social groups, seem to play a significant role in smoking habits of cancer patients.